In addition, several previous studies have reported that FMN could exert a range of pharmacological activities, including anti-atherosclerosis, anti-tumor, and selective neuroprotective effects (El-Bakoush and Olajide, 2018; Ong et al., 2019; Ma et al., 2020). This evidence concerns the gene FMN1 and neoplasm.